Strive (ASST) has had the highest return between August 12, 2026 and September 12, 2026 by a mid-cap US stock in the Nasdaq Composite (IXIC), returning 114.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Strive (ASST) | 8/12/2026 - 9/12/2026 | 114.77% |
Hyperliquid Strategies Inc Common Stock (PURR) | 8/12/2026 - 9/12/2026 | 71.24% |
Heartflow, Inc Common Stock (HTFL) | 8/12/2026 - 9/12/2026 | 68.57% |
Aveanna Healthcare (AVAH) | 8/12/2026 - 9/12/2026 | 58.2% |
Ionic Digital Inc Class A Common Stock (IOND) | 8/12/2026 - 9/12/2026 | 41.34% |
Amylyx Pharmaceuticals (AMLX) | 8/12/2026 - 9/12/2026 | 32.52% |
Iovance Biotherapeutics (IOVA) | 8/12/2026 - 9/12/2026 | 32.51% |
Torm PLC Class A (TRMD) | 8/12/2026 - 9/12/2026 | 32.3% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 8/12/2026 - 9/12/2026 | 28.88% |
AtriCure (ATRC) | 8/12/2026 - 9/12/2026 | 28.81% |
Calumet Specialty Products Partners (CLMT) | 8/12/2026 - 9/12/2026 | 23.51% |
Silicon Motion Technology (SIMO) | 8/12/2026 - 9/12/2026 | 23.37% |
Figure Technology Solutions, Inc Class A Common Stock (FIGR) | 8/12/2026 - 9/12/2026 | 20.99% |
Slide Insurance Holdings, Inc Common Stock (SLDE) | 8/12/2026 - 9/12/2026 | 20.86% |
Webull (BULL) | 8/12/2026 - 9/12/2026 | 20.37% |
Chagee Holdings Limited American Depositary Shares (CHA) | 8/12/2026 - 9/12/2026 | 20.12% |
Qorvo (QRVO) | 8/12/2026 - 9/12/2026 | 19.85% |
Pulse Biosciences (PLSE) | 8/12/2026 - 9/12/2026 | 19.62% |
VEON (VEON) | 8/12/2026 - 9/12/2026 | 19.51% |
BGC (BGC) | 8/12/2026 - 9/12/2026 | 18.95% |
Abcellera Biologics (ABCL) | 8/12/2026 - 9/12/2026 | 18.11% |
Patterson-UTI Energy (PTEN) | 8/12/2026 - 9/12/2026 | 17.75% |
Wix (WIX) | 8/12/2026 - 9/12/2026 | 17.2% |
10X Genomics (TXG) | 8/12/2026 - 9/12/2026 | 17.03% |
Star Bulk Carriers (SBLK) | 8/12/2026 - 9/12/2026 | 16.93% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.